Table of Contents

1 Market Overview

• 1.1 Objectives of Research
  • 1.1.1 Definition

Figure Liposomes Drug Delivery Picture

• 1.1.2 Specifications

Table Product Specifications of Liposomes Drug Delivery

• 1.2 Market Segment
  • 1.2.1 by Type

Table Products Segment of Liposomes Drug Delivery

Table Global Liposomes Drug Delivery Market by Type, 2011-2022 (USD Million)

• 1.2.1.1 Liposomal doxorubicin

Table Liposomal doxorubicin Overview

• 1.2.1.2 Liposomal Amphoteracin B

Table Liposomal Amphoteracin B Overview

• 1.2.1.3 Liposomal Paclitaxel

Table Liposomal Paclitaxel Overview

• 1.2.1.4 Others

Table Others Overview

• 1.2.2 by Application

Table Application Segment of Liposomes Drug Delivery

Table Global Liposomes Drug Delivery Market by Application, 2011-2022 (USD Million)

• 1.2.2.1 Fungal Infection Therapy

Table Fungal Infection Therapy Overview

• 1.2.2.2 Cancer Therapy ( Tumor therapy)

Table Cancer Therapy ( Tumor therapy) Overview

• 1.2.2.3 Others

Table Others Overview

• 1.2.3 by Regions

Table Global Liposomes Drug Delivery Market by Region, 2011-2022 (USD Million)

2 Industry Chain

• 2.1 Industry Chain Structure

Figure Industry Chain Structure of Liposomes Drug Delivery

• 2.2 Upstream

Table Cost of Liposomes Drug Delivery

Figure Manufacturing Process of Liposomes Drug Delivery

• 2.3 Market
  • 2.3.1 SWOT

Figure SWOT of Liposomes Drug Delivery

• 2.3.2 Dynamics

Table Market Dynamics

3 Environmental Analysis

• 3.1 Policy

Table Policy of Liposomes Drug Delivery

• 3.2 Economic

Table GDP of Major Countries

• 3.3 Technology

Table Technology of Liposomes Drug Delivery

• 3.4 Market Entry

Table Market Entry of Liposomes Drug Delivery

4 Market Segmentation by Type

• 4.1 Market Size
  • 4.1.1 Liposomal doxorubicin Market, 2013-2018

Figure Liposomal doxorubicin Market Size and Growth, 2012-2018 (USD Million)

Figure Liposomal doxorubicin Market Size and Growth, 2012-2018 (in Volume)

Table Liposomal doxorubicin CAGR by Revenue and Volume, 2012-2018

• 4.1.2 Liposomal Amphoteracin B Market, 2013-2018

Figure Liposomal Amphoteracin B Market Size and Growth, 2012-2018 (USD Million)

Figure Liposomal Amphoteracin B Market Size and Growth, 2012-2018 (in Volume)

Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2018

• 4.1.3 Liposomal Paclitaxel Market, 2013-2018

Figure Liposomal Paclitaxel Market Size and Growth, 2012-2018 (USD Million)

Figure Liposomal Paclitaxel Market Size and Growth, 2012-2018 (in Volume)

Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2018

• 4.1.4 Others Market, 2013-2018

Figure Others Market Size and Growth, 2012-2018 (USD Million)

Figure Others Market Size and Growth, 2012-2018 (in Volume)

Table Others CAGR by Revenue and Volume, 2012-2018

• 4.2 Market Forecast
  • 4.2.1 Liposomal doxorubicin Market Forecast, 2020-2025

Figure Liposomal doxorubicin Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Liposomal doxorubicin Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Liposomal doxorubicin CAGR by Revenue and Volume, 2012-2024

• 4.2.2 Liposomal Amphoteracin B Market Forecast, 2020-2025

Figure Liposomal Amphoteracin B Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Liposomal Amphoteracin B Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Liposomal Amphoteracin B CAGR by Revenue and Volume, 2012-2024

• 4.2.3 Liposomal Paclitaxel Market Forecast, 2020-2025

Figure Liposomal Paclitaxel Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Liposomal Paclitaxel Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Liposomal Paclitaxel CAGR by Revenue and Volume, 2012-2024

• 4.2.4 Others Market Forecast, 2020-2025

Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Others CAGR by Revenue and Volume, 2012-2024

5 Market Segmentation by Application

• 5.1 Market Size
  • 5.1.1 Fungal Infection Therapy Market, 2013-2018

Figure Fungal Infection Therapy Market Size and Growth, 2012-2018 (USD Million)

Figure Market Size and Growth, 2012-2018 (in Volume)

Table Fungal Infection Therapy CAGR by Revenue and Volume, 2012-2018

• 5.1.2 Cancer Therapy ( Tumor therapy) Market, 2013-2018

Figure Cancer Therapy ( Tumor therapy) Market Size and Growth, 2012-2018 (USD Million)

Figure Market Size and Growth, 2012-2018 (in Volume)

Table Cancer Therapy ( Tumor therapy) CAGR by Revenue and Volume, 2012-2018

• 5.1.3 Others Market, 2013-2018

Figure Others Market Size and Growth, 2012-2018 (USD Million)

Figure Market Size and Growth, 2012-2018 (in Volume)

Table Others CAGR by Revenue and Volume, 2012-2018

• 5.2 Market Forecast
  • 5.2.1 Fungal Infection Therapy Market Forecast, 2020-2025

Figure Fungal Infection Therapy Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Fungal Infection Therapy Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Fungal Infection Therapy CAGR by Revenue and Volume, 2020-2025

• 5.2.2 Cancer Therapy ( Tumor therapy) Market Forecast, 2020-2025

Figure Cancer Therapy ( Tumor therapy) Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Cancer Therapy ( Tumor therapy) Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Cancer Therapy ( Tumor therapy) CAGR by Revenue and Volume, 2020-2025

• 5.2.3 Others Market Forecast, 2020-2025

Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Others CAGR by Revenue and Volume, 2020-2025

6 Market Segmentation by Region

• 6.1 Market Size
  • 6.1.1 Asia-Pacific
    • 6.1.1.1 Asia-Pacific Market, 2012-2018

  Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)

  Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)

  Table Asia-Pacific CAGR by Revenue and Volume, 2012-2018

  • 6.1.1.2 Asia-Pacific Market by Type

Figure Asia-Pacific Market Size by Type

Figure Asia-Pacific Market Share by Type

• 6.1.1.3 Asia-Pacific Market by Application

Figure Asia-Pacific Market Size by Application

Figure Asia-Pacific Market Share by Application

• 6.1.2 North America
  • 6.1.2.1 North America Market, 2012-2018

Figure North America Market Size and Growth, 2012-2018 (USD Million)

Figure North America Market Size and Growth, 2012-2018 (in Volume)

Table North America CAGR by Revenue and Volume, 2012-2018

• 6.1.2.2 North America Market by Type

Figure North America Market Size by Type

Figure North America Market Share by Type

• 6.1.2.3 North America Market by Application

Figure North America Market Size by Application

Figure North America Market Share by Application

• 6.1.3 Europe
  • 6.1.3.1 Europe Market, 2012-2018

Figure Europe Market Size and Growth, 2012-2018 (USD Million)

Figure Europe Market Size and Growth, 2012-2018 (in Volume)

Table Europe CAGR by Revenue and Volume, 2012-2018

• 6.1.3.2 Europe Market by Type

Figure Europe Market Size by Type

Figure Europe Market Share by Type

• 6.1.3.3 Europe Market by Application

Figure Europe Market Size by Application

Figure Europe Market Share by Application

• 6.1.4 South America
  • 6.1.4.1 South America Market, 2012-2018

Figure South America Market Size and Growth, 2012-2018 (USD Million)

Figure South America Market Size and Growth, 2012-2018 (in Volume)

Table South America CAGR by Revenue and Volume, 2012-2018

• 6.1.4.2 South America Market by Type

Figure South America Market Size by Type

Figure South America Market Share by Type

• 6.1.4.3 South America Market by Application

Figure South America Market Size by Application

Figure South America Market Share by Application

• 6.1.5 Middle East & Africa
  • 6.1.5.1 Middle East & Africa Market, 2012-2018

Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)

Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2012-2018

• 6.1.5.2 Middle East & Africa Market by Type

Figure Middle East & Africa Market Size by Type

Figure Middle East & Africa Market Share by Type

• 6.1.5.3 Middle East & Africa Market by Application

Figure Middle East & Africa Market Size by Application

Figure Middle East & Africa Market Share by Application

• 6.2 Market Forecast
  • 6.2.1 Asia-Pacific Market Forecast, 2020-2025

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025

• 6.2.2 North America Market Forecast, 2020-2025

Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table North America CAGR by Revenue and Volume, 2020-2025

• 6.2.3 Europe Market Forecast, 2020-2025

Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Europe CAGR by Revenue and Volume, 2020-2025

• 6.2.4 South America Market Forecast, 2020-2025

Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)

Table South America CAGR by Revenue and Volume, 2020-2025

• 6.2.5 Middle East & Africa Market Forecast, 2020-2025

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025

7 Market Competitive

• 7.1 Global Market by Vendors

Table Global Liposomes Drug Delivery Market by Vendors, 2012-2018 (in Volume)

Table Global Liposomes Drug Delivery Market Share by Vendors, 2012-2018 (USD Million)

Table Global Liposomes Drug Delivery Market Share by Vendors, 2012-2018 (in Volume)

• 7.2 Market Concentration

Figure Liposomes Drug Delivery Market Concentration by Region

• 7.3 Price & Factors

Table Price Factors List

• 7.4 Marketing Channel

Figure Marketing Channels Overview

8 Major Vendors

• 8.1 Johnson & Johnson

Table Johnson & Johnson Profile List

Table Microecological Modulator Operating Data of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.2 Gilead Sciences

Table Gilead Sciences Profile List

Table Microecological Modulator Operating Data of Gilead Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.3 Luye Pharma

Table Luye Pharma Profile List

Table Microecological Modulator Operating Data of Luye Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.4 Sun Pharmaceutical

Table Sun Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Sun Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.5 Pacira

Table Pacira Profile List

Table Microecological Modulator Operating Data of Pacira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.6 Fudan-Zhangjiang

Table Fudan-Zhangjiang Profile List

Table Microecological Modulator Operating Data of Fudan-Zhangjiang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.7 Sigma-Tau Group

Table Sigma-Tau Group Profile List

Table Microecological Modulator Operating Data of Sigma-Tau Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.8 Teva Pharmaceutical

Table Teva Pharmaceutical Profile List

Table Microecological Modulator Operating Data of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.9 CSPC

Table CSPC Profile List

Table Microecological Modulator Operating Data of CSPC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.10 Novartis

Table Novartis Profile List

Table Microecological Modulator Operating Data of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.11 Crucell

Table Crucell Profile List

Table Microecological Modulator Operating Data of Crucell (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.12 Celsion Corporation

Table Celsion Corporation Profile List

Table Microecological Modulator Operating Data of Celsion Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.13 Kingond Pharm

Table Kingond Pharm Profile List

Table Microecological Modulator Operating Data of Kingond Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.14 Shanghai New Asia

Table Shanghai New Asia Profile List

Table Microecological Modulator Operating Data of Shanghai New Asia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 8.15 Spectrum Pharmaceuticals

Table Spectrum Pharmaceuticals Profile List

Table Microecological Modulator Operating Data of Spectrum Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

9 Conclusion

Summary

Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global Liposomes Drug Delivery market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Liposomal doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Johnson & Johnson
Gilead Sciences
Luye Pharma
Sun Pharmaceutical
Pacira
Fudan-Zhangjiang
Sigma-Tau Group
Teva Pharmaceutical
CSPC
Novartis
Crucell
Celsion Corporation
Kingond Pharm
Shanghai New Asia
Spectrum Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Fungal Infection Therapy
Cancer Therapy ( Tumor therapy)
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa